Stock Financial Ratios, Dividends, Split History

DYN / Dynegy Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price12.81
Volume22,175,200.00
Market Cap ($M)1,849.65
Book Value ($M)1,901.00
Book Value / Share13.17
Price / Book0.97
NCAV ($M)-8,354.00
NCAV / Share-57.86
Price / NCAV-0.22
Share Statistics
Preferred Stock Shares Outstanding 0
Common Stock Shares Outstanding 144,384,491
Weighted Average Number Of Diluted Shares Outstanding 162,000,000
Weighted Average Number Diluted Shares Outstanding Adjustment 7,000,000
Common Shares Outstanding 144,390,952
Weighted Average Number Of Shares Outstanding Basic 155,000,000
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.01
Return on Assets (ROA)0.01
Return on Equity (ROE)0.04
Balance Sheet (mrq) ($M)
Assets11,771.00
Liabilities9,878.00
Quick Ratio1.03
Current Ratio1.45
Income Statement (mra) ($M)
Results Of Operations Sales Revenue To Unaffiliated Enterprises4,842,000,000.00
Electrical Generation Revenue4,842,000,000.00
Operating Income-412.00
Net Income72.00
Earnings Per Share Diluted0.36
Earnings Per Share Basic0.37
Cash Flow Statement (mra) ($M)
Cash From Operations585.00
Cash from Investing-2,759.00
Cash from Financing-2,759.00
Identifiers and Descriptors
CUSIP26817R108
Central Index Key (CIK)1379895
Related CUSIPS
26817G300 26817R405 26817R908 26817R116 26817R157 26817R958

Split History

Stock splits are used by Dynegy Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Charah Solutions IPO: Undervalued, But Large Financial Risk

2018-06-09 seekingalpha
Leverage is very significant. The company will use the proceeds from the IPO to repay the debt. (93-0)

Vistra Energy (VST) Surges: Stock Moves 5.8% Higher

2018-04-10 zacks
Vistra Energy Corp. (VST - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $19.68–$21.13 in the past one-month time frame, witnessed a sharp increase yesterday. (24-0)

Zacks.com featured highlights include: Weight Watchers, Match, Dynegy and HFF

2018-04-10 zacks
Chicago, IL – April 10, 2018 - Stocks in this week’s article Weight Watchers International, Inc. (WTW - Free Report) , Match Group, Inc. (MTCH - Free Report) , Dynegy Inc. and HFF, Inc. (HF - Free Report) . (32-0)

4 Hot Momentum Stocks for Impressive Returns

2018-04-09 zacks
When value or growth investing fails to fetch sustained profits, one should explore another time-tested winning strategy that simply bets on the frontrunner stocks. Translated, one of the most successful strategies today is to get in on momentum stocks at the right time. (9-0)

Robust Private Sector Hiring in March: 5 Top-Ranked Picks

2018-04-05 zacks
U.S. private sector employers made robust job additions in March, per a Automatic Data Processing Inc. ("ADP") and Moody’s Analytics report dated Apr 4. In fact, data from the same proved that the negative market sentiment about U.S. tariffs imposed on steel and aluminum by President Trump was overblown. Also, the U.S. Labor Department’s report released on Mar 9 showed that the economy added 313,000 jobs in February 2018, exceeding the consensus estimate of 208,000. (67-0)

CUSIP: 26817R108